FDA reorganization is out for review, but impact later in 2024 could be huge - LexBlog
The FDA’s largest reorganization in history, involving about 8,000 employees, is far more than just “moving some boxes around.” The proposed changes and updates to an FDA-wide reorganization plan have been out for external reviews and clearances since Dec. 13, 2023, and implementation should occur sometime during 2024.